Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis

被引:110
|
作者
Kaburagi, Y [1 ]
Shimada, Y [1 ]
Nagaoka, T [1 ]
Hasegawa, M [1 ]
Takehara, K [1 ]
Sato, S [1 ]
机构
[1] Kanazawa Univ, Sch Med, Dept Dermatol, Kanazawa, Ishikawa 9208641, Japan
关键词
CC-chemokine; atopic dermatitis; inflammation;
D O I
10.1007/s004030100230
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
CC-chemokines are potent molecules that direct the migration of leukocytes to inflammatory foci. To determine their role in inflammation associated with atopic dermatitis (AD), we determined serum levels and spontaneous production of CC-chemokines by peripheral blood mononuclear cells (PBMC) in AD patients using an ELISA. Serum levels of RANTES, MCP-1, MIP-1 beta, and eotaxin were increased in AD patients (n = 52) compared with normal controls (n = 22). Serum levels of RANTES, MCP-1, and MIP-1 beta were increased in AD patients with severe disease (n = 19) compared with normal controls (n = 22). Spontaneous production of RANTES, MCP-1, MIP-1 alpha and MIP-1 beta by PBMC was augmented in AD patients (n = 39) and in patients with severe AD (n = 14) compared with normal controls (n = 20). Serum RANTES levels correlated with total serum IgE levels, eosinophil numbers, and serum lactate dehydrogenase levels. Our results suggest that augmented production of CC-chemokines correlates with inflammation associated with AD.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 50 条
  • [1] Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1α, MIP-1β, and eotaxin) in patients with atopic dermatitis
    Yuko Kaburagi
    Yuka Shimada
    Tetsuya Nagaoka
    Minoru Hasegawa
    Kazuhiko Takehara
    S. Sato
    Archives of Dermatological Research, 2001, 293 : 350 - 355
  • [2] Synthesis of the CC-chemokines MIP-1 alpha, MIP-1 beta, and RANTES is associated with a type 1 immune response
    Schrum, S
    Probst, P
    Fleischer, B
    Zipfel, PF
    JOURNAL OF IMMUNOLOGY, 1996, 157 (08): : 3598 - 3604
  • [3] Expression of the chemokines MIP-1α, MCP-1, and RANTES in experimental autoimmune uveitis
    Crane, IJ
    McKillop-Smith, S
    Wallace, CA
    Lamont, GR
    Forrester, JV
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (07) : 1547 - 1552
  • [4] Evaluation of the chemokines MIP-1α, MIP-1β and RANTES in human cardiac disease
    Hertz, G
    Tan, CD
    Parrillo, JE
    Rodriguez, ER
    LABORATORY INVESTIGATION, 1998, 78 (01) : 33A - 33A
  • [5] Evaluation of the chemokines MIP-1α, MIP-1β and RANTES in human cardiac disease
    Hertz, G
    Tan, CD
    Parrillo, JE
    Rodriguez, ER
    MODERN PATHOLOGY, 1998, 11 (01) : 33A - 33A
  • [6] Effect of pharmacological intervention on MIP-1 α, MIP-1 β and MCP-1 expression in patients with psoriasis vulgaris
    Dai, Yong-Jiang
    Li, Yu-Yang
    Zeng, Hui-Ming
    Liang, Xiong-An
    Xie, Zhi-Jie
    Zheng, Zhi-Ang
    Pan, Qin-Hui
    Xing, Yi-Xiong
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2014, 7 (07) : 582 - 584
  • [7] Effect of pharmacological intervention on MIP-1α,MIP-1β and MCP-1 expression in patients with psoriasis vulgaris
    Yong-Jiang Dai
    Yu-Yang Li
    Hui-Ming Zeng
    Xiong-An Liang
    Zhi-Jie Xie
    Zhi-Ang Zheng
    Qin-Hui Pan
    Yi-Xiong Xing
    Asian Pacific Journal of Tropical Medicine, 2014, (07) : 582 - 584
  • [8] Increased expression of chemokines (MCP-1, MIP-1α, RANTES) after peripheral nerve transection
    Taskinen, HS
    Röyttä, M
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2000, 5 (02) : 75 - 81
  • [9] Augmented production of chemokines (monocyte chemotactic protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis:: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis
    Hasegawa, M
    Sato, S
    Takehara, K
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 117 (01): : 159 - 165
  • [10] Serum RANTES, MIP-1α, and MCP-1 levels in Behcet's disease
    Ozer, HTE
    Erken, E
    Gunesacar, R
    Kara, O
    RHEUMATOLOGY INTERNATIONAL, 2005, 25 (06) : 487 - 488